Permanently Discontinued

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 125MG has been permanently discontinued (last updated February 13, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file2 products · 1 same form & route

Affected strength125MG

Report last updated2020-02-13

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

SOLU-MEDROL

PFIZER CANADA ULC

500MG · DIN 00030678

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

DEPO-MEDROL

PFIZER CANADA ULC

40MG · DIN 00030759

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02231894

Strength

125MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAMUSCULAR INTRAVENOUS

Active Ingredient

METHYLPREDNISOLONE

See all METHYLPREDNISOLONE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2020-02-13

Active Shortage

Disruption of the manufacture of the drug.

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163